A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND)

International Journal of Stroke

Volumn 7, Issue 1, 2012, Pages 74-80

  Ma, Henry ^a,b   Parsons, Mark W ^c   Christensen, Soren ^a   Campbell, Bruce C V ^a   Churilov, Leonid ^a   Connelly, Alan ^d   Yan, Bernard ^a   Bladin, Chris ^e   Phan, Than ^b   Barber, Alan P ^f   Read, Stephen ^g   Hankey, Graeme J ^h   Markus, Romesh ⁱ   Wijeratne, Tissa ^j   Grimley, R ^k   Mahant, N ^l   Kleinig, Tim ^m   Sturm, John ^c   Lee, A ⁿ   Blacker, D ^o   Gerraty, Richard ^b,p   Krause, M ^q   Desmond, P M ^r   Mcbride, S J ^t   Carey, Leanne ^a   Howells, David W ^a   Hsu, C Y ^s   Davis, Stephen M ^a   Donnan, Geoffrey A ^a   more..

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^e BOX HILL HOSPITAL   (Australia)

^f AUCKLAND CITY HOSPITAL   (New Zealand)

^g ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^h ROYAL PERTH HOSPITAL   (Australia)

ⁱ ST VINCENT S HOSPITAL   (Australia)

^j WESTERN HEALTH   (Australia)

^k Nambour General Hospital   (Australia)

^l WESTMEAD HOSPITAL   (Australia)

^m ROYAL ADELAIDE HOSPITAL   (Australia)

ⁿ FLINDERS MEDICAL CENTRE   (Australia)

^o SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^p EPWORTH HEALTHCARE   (Australia)

^q ROYAL NORTH SHORE HOSPITAL   (Australia)

^r ROYAL MELBOURNE HOSPITAL   (Australia)

^s CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^t CSIRO   (Australia)

more..

Author keywords

Clinical trials; EXTEND; Protocols; Stroke; Thrombolysis; Time window

Indexed keywords

PLACEBO; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; DRUG MONITORING; DRUG SAFETY; EXTENDING THE TIME FOR THROMBOLYSIS IN EMERGENCY NEUROLOGICAL DEFICIT; FIBRINOLYTIC THERAPY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

DOUBLE-BLIND METHOD; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RESEARCH DESIGN; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84155184488     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2011.00730.x     Document Type: Article

References (24)

1. Hacke W, Kaste M, Bluhmki E etal. Thrombolysis with alteplase 3 to 4·5hours after acute ischemic stroke. N Engl J Med 2008; 359:1317-1329.
2. Khaja AM, Grotta JC. Established treatments for acute ischaemic stroke. Lancet 2007; 369:319-330.
3. Darby DG, Barber PA, Gerraty RP etal. Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke 1999; 30:2043-2052.
4. Markus R, Reutens DC, Kazui S etal. Hypoxic tissue in ischaemic stroke: persistence and clinical consequences of spontaneous survival. Brain 2004; 127:1427-1436.
5. Lees KR, Bluhmki E, von Kummer R etal. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 375:1695-1703.
6. Muir KW, Buchan A, von Kummer R, Rother J, Baron J-C. Imaging of acute stroke. Lancet Neurol 2006; 5:755-768.
7. Albers GW, Thijs VN, Wechsler L etal. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study. Ann Neurol 2006; 60:508-517.
8. Mlynash M, Lansberg MG, De Silva DA etal. on behalf of the D-EI. Refining the definition of the malignant profile: insights from the defuse-epithet pooled data set. Stroke 2011; 42:1270-1275.
9. Davis SM, Donnan GA, Parsons MW etal. Effects of alteplase beyond 3h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008; 7:299-309.
10. Nagakane Y, Christensen S, Brekenfeld C etal. for the EI. EPITHET: positive result after reanalysis using baseline diffusion-weighted imaging/perfusion-weighted imaging co-registration. Stroke 2011; 42:59-64.
11. Olivot J-M, Mlynash M, Thijs VN etal. Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke 2009; 40:469-475.
12. Zaro-Weber O, Moeller-Hartmann W, Heiss W-D, Sobesky J. Maps of time to maximum and time to peak for mismatch definition in clinical stroke studies validated with positron emission tomography. Stroke 2010; 41:2817-2821.
13. Christensen SCB, Perez de la Ossa N, Lansberg MG etal. Optimal perfusion thresholds for prediction of tissue destined for infarction in the combined epithet and defuse dataset. Stroke 2011; 41:e297.
14. Parsons MW, Christensen S, McElduff P etal. Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab 2010; 30:1214-1225.
15. Yoo AJ, Verduzco LA, Schaefer PW, Hirsch JA, Rabinov JD, Gonzalez RG. MRI-based selection for intra-arterial stroke therapy: value of pretreatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will benefit from early recanalization. Stroke 2009; 40:2046-2054.
16. Bivard A, McElduff P, Spratt N, Levi C, Parsons M. Defining the extent of irreversible brain ischemia using perfusion computed tomography. Cerebrovasc Dis 2011; 31:238-245.
17. Kamalian S, Kamalian S, Maas MB etal. CT cerebral blood flow maps optimally correlate with admission diffusion-weighted imaging in acute stroke but thresholds vary by postprocessing platform. Stroke 2011; 42:1923-1928.
18. Campbell BCV, Christensen S, Levi CR etal. Cerebral blood flow is the optimal CT perfusion parameter for assessing infarct core. Stroke 2011; doi: 10.1161/STROKEAHA.111.618355.
19. Huisa BN, Raman R, Ernstrom K etal. Alberta stroke program early CT score (aspects) in patients with wake-up stroke. J Stroke Cerebrovasc Dis 2010; 19:475-479.
20. Silva GS, Lima FO, Camargo ECS etal. Wake-up stroke: clinical and neuroimaging characteristics. Cerebrovasc Dis 2010; 29:336-342.
21. Wintermark M, Albers GW, Alexandrov AV etal. Acute stroke imaging research roadmap. Stroke 2008; 39:1621-1628.
22. Campbell BCV, Tu HT, Christensen S etal. Assessing response to stroke thrombolysis: validation of 24h multimodal MRI. Arch Neurol 2011; doi:10.1001/archneurol.2011.232.
23. Wahlgren N, Ahmed N, Davalos A etal. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369:275-282.
24. Altman DG, Schulz KF, Moher D etal. The revised consort statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134:663-694.